Want to join the conversation?
$DOV generated a strong free cash flow of $243MM or 14% of revenue in 3Q15. For the full year 2015, it expects to generate free cash flow of about 12% of revenue, up one point from its prior estimate. $DOV repurchased 1.5MM shares for $100MM during 3Q15 and have repurchased $600MM YTD, completing its repurchase plans for the year.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.